Keywords: texas, novastan, non-approvable, biotechnology, received, letter, usfood

Texas' Novastan Is "Non-Approvable"

Article | 14 May 1998

Texas Biotechnology has received a non-approvable letter from the USFood and Drug Administration regarding its anticoagulant therapy Novastan (argatroban) for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Heparin

Argatroban

Argatroban Injection

Go to drug listing